Could also be the reason the havnt pulled the trigger on funding yet.
Ongoing discussions
- Forums
- ASX - By Stock
- Ann: Emyria expands clinical sites for EMD-RX5 Phase 3 trial
EMD
emyria limited
Add to My Watchlist
2.44%
!
4.2¢

Could also be the reason the havnt pulled the trigger on funding...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $25.06M |
Open | High | Low | Value | Volume |
4.1¢ | 4.2¢ | 4.1¢ | $43.37K | 1.042M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 458107 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.3¢ | 673095 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 458107 | 0.042 |
1 | 1000000 | 0.041 |
2 | 500000 | 0.040 |
4 | 152285 | 0.039 |
8 | 466758 | 0.038 |
Price($) | Vol. | No. |
---|---|---|
0.043 | 673095 | 2 |
0.044 | 735000 | 3 |
0.045 | 525000 | 2 |
0.046 | 25000 | 1 |
0.047 | 25000 | 1 |
Last trade - 10.37am 30/07/2025 (20 minute delay) ? |
Featured News
EMD (ASX) Chart |